CTOs on the Move

Mortara Instrument

www.mortara.com

 
Founded in 1982 by David W. Mortara, PhD, Mortara Instrument was born with a guiding philosophy: design to a need, keep it simple, and make it economically accessible. Building on this philosophy, Mortara Instrument has created a complete line of
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.mortara.com
  • 7865 N 86th St
    Milwaukee, WI USA 53224
  • Phone: 414.354.1600

Executives

Name Title Contact Details

Similar Companies

LifeScan

LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust.

Keystone Industries

Keystone Industries is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Surgalign

Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany.

EPICENTRE

EPICENTRE is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cyrano Therapeutics

The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being.